ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1250 • ACR Convergence 2020

    Early Sjögren Antibodies: Potential Biomarker for Abnormal Minor Labial Salivary Gland Biopsy in Juvenile Sjögren’s Syndrome

    Akaluck Thatayatikom1, Sthorn Thatayatikom1, Indraneel Bhattacharyya2, Melissa Elder1, Renee Modica1 and Seunghee Cha2, 1Department of Pediatrics, University of Florida, Gainesville, FL, 2College of Dentistry, University of Florida, Gainesville, FL

    Background/Purpose: Juvenile Sjögren’s Syndrome (jSS) is a perplexing systemic autoimmune disease in children presenting with positive autoantibodies, glandular, and/ or extraglandular symptoms. In pediatric practice,…
  • Abstract Number: 1251 • ACR Convergence 2020

    Assessing the Construct Validity of the Novel OMERACT Ultrasound Scoring System for Salivary Glands Target Lesions by Comparison with MRI in Patients with Sjögren’s Syndrome – An OMERACT Ultrasound Working Group Exercise

    Nevsun Inanc1, Sandrine Jousse-Joulin2, Kerem Abacar3, Çagatay Cimşit4, Canan Cimşit4, Maria D’Agostino5, Esperanza Naredo6, Alojzija Hocevar7, Stephanie Finzel8, Lene Terslev9, Annamaria Iagnocco10, Petra Hanova11, Wolfgang Schmidt12, Gonca Mumcu13 and George A. Bruyn14, 1Marmara University, School of Medicine, Division of Rheumatology, istanbul, Turkey, 2Rheumatology Department, Cavale Blanche Hospital and Brest Occidentale University, Brest, France, 3Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey, 4Marmara University School of Medicine, Radiology, Istanbul, Istanbul, Turkey, 5Université Versailles Saint Quentin, Ambroise Paré Hospital, Paris, France, 6Department of Rheumatology, Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz and Universidad Autónoma de Madrid, Madrid, Spain, 7University Medical Center, Rheumatology, Ljubljana, LJUBLJANA, Slovenia, 8Universitätsklinikum Freiburg, Klinik für Rheumatologie und Klinische Immunologie, Freiburg, Germany, 9Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Copenhagen, Denmark, 10Università degli Studi di Torino, Academic Rheumatology Centre, Turin, Italy, 11Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 12Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany, 13Marmara University School of Health Sciences, Health Management, Istanbul, Istanbul, Turkey, 14Rheumatology, Reumakliniek Lelystad, Lelystad, Netherlands

    Background/Purpose: Imaging techniques such as salivary gland ultrasound and magnetic resonance imaging (MRI) are able to diagnose primary Sjögren syndrome (pSS) patients with high sensitivity…
  • Abstract Number: 1252 • ACR Convergence 2020

    Ultrasound-guided Parotid Gland Biopsy in Cadavers Performed by Rheumatologists – an OMERACT Ultrasound Working Group Study

    Nevsun Inanc1, Sandrine Jousse-Joulin2, Kerem Abacar3, Leyla Cinel4, Maria D’Agostino5, Esperanza Naredo6, Alojzija Hocevar7, Stephanie Finzel8, Lene Terslev9, Annamaria Iagnocco10, Petra Hanova11, Wolfgang Schmidt12, Gonca Mumcu13, Ümit S. Şehirli14 and George A. Bruyn15, 1Marmara University, School of Medicine, Division of Rheumatology, istanbul, Turkey, 2Rheumatology Department, Cavale Blanche Hospital and Brest Occidentale University, Brest, France, 3Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey, 4Marmara University, School of Medicine, Division of Pathology, Istanbul, Turkey, 5Université Versailles Saint Quentin, Ambroise Paré Hospital, Paris, France, 6Department of Rheumatology, Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz and Universidad Autónoma de Madrid, Madrid, Spain, 7University Medical Center, Rheumatology, Ljubljana, LJUBLJANA, Slovenia, 8Universitätsklinikum Freiburg, Klinik für Rheumatologie und Klinische Immunologie, Freiburg, Germany, 9Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Copenhagen, Denmark, 10Università degli Studi di Torino, Academic Rheumatology Centre, Turin, Italy, 11Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 12Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany, 13Marmara University School of Health Sciences, Health Management, Istanbul, Istanbul, Turkey, 14Marmara University, School of Medicine, Anatomy, Istanbul, Turkey, 15Rheumatology, Reumakliniek Lelystad, Lelystad, Netherlands

    Background/Purpose: With the diagnostic capability of the parotid gland biopsy similar to minor salivary gland biopsy in Sjögren’s syndrome, the parotid gland biopsy may also…
  • Abstract Number: 1253 • ACR Convergence 2020

    Re-evaluation of the Extent of Lymphocytic Infiltration May Improve the Diagnostic Accuracy of Lip Biopsy in Primary Sjögren’s Syndrome (pSS)

    Chiara Baldini1, Francesco Ferro1, Gianmaria Governato1, Giovanni Fulvio2, Elena Elefante3, Marta Mosca1, Stefano Bombardieri1 and Valentina Donati4, 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 2Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 3Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa; Department of Medical Biotechnology, University of Siena, Pisa, Italy, 4Pathology Unit, AOUP, Pisa

    Background/Purpose: Focus score (FS) remains the key element for the histological diagnosis of pSS; nonetheless, additional parameters have been proposed for clinical trials including the…
  • Abstract Number: 1254 • ACR Convergence 2020

    Lack of Efficacy of Early Treatment with Hydroxychloroquine in a Group of Hispanics with Primary Sjögren’s Syndrome

    Ariana González-Meléndez1, Patricia Jordán-González1, Ricardo Gago-Piñero1, Noemí Varela-Rosario1, Naydi Pérez-Ríos1 and Luis Vilá1, 1University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

    Background/Purpose: Treatment of primary Sjögren’s syndrome (pSS) with hydroxychloroquine (HCQ) has been evaluated in the past but with conflicting results regarding its efficacy. While earlier…
  • Abstract Number: 1255 • ACR Convergence 2020

    Sjӧgren’s Syndrome Minor Salivary Gland Mesenchymal Stromal Cells Derived Deploy Intact Immune Plasticity and Display Myofibroblast-Like Properties

    Sara McCoy1, Jayeeta Giri1, Rahul Das1, Pradyut Paul1, Andrea Pennati1, Maxwell Parker1, Yun Liang1 and Jacques Galipeau1, 1University of Wisconsin, Madison

    Background/Purpose: Primary Sjӧgren’s syndrome (pSS) is the second most common systemic autoimmune disease with hallmark features of severe ocular and oral sicca, leading to reduced…
  • Abstract Number: 1256 • ACR Convergence 2020

    Mast Cells Contribute to the Development of Sialadenitis Associated with Sjögren’s Syndrome via Inducing Tissue Fibrosis by TGFβ Production

    Shinjiro Kaieda1, Kyoko Fujimoto1 and Hiroaki Ida1, 1Kurume University School of Medicine, Kurume, Japan

    Background/Purpose: Mast cells have been implicated in many immune-inflammatory disorders. They mediate a variety of inflammatory and fibrotic conditions, but their role in sialadenitis in…
  • Abstract Number: 1257 • ACR Convergence 2020

    Gestational Diabetes Mellitus in Pregnant Women with Systemic Lupus Erythematosus

    Sofia Gernaat1, Julia Simard2, Elisabet Svenungsson3 and Elizabeth Arkema4, 1Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 2Stanford Medicine, Stanford, CA, 3Karolinska University Hospital, Stockholm, Sweden, 4Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Increased insulin resistance is pivotal in the development of gestational diabetes mellitus (GDM). Women with SLE may be at higher risk of GDM due…
  • Abstract Number: 1258 • ACR Convergence 2020

    Trajectory of Damage Accrual in African-American vs. Caucasian Systemic Lupus Erythematosus

    Romy Kallas1, Jessica Li2, Daniel Goldman3 and Michelle Petri3, 1Johns Hopkins Medical Institution, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: African-Americans have a higher incidence/prevalence of SLE, more lupus nephritis, higher rates of end stage renal disease and higher mortality than Caucasians. The aim…
  • Abstract Number: 1259 • ACR Convergence 2020

    The Impact of Antimalarial Agents on Traditional and Non-traditional Cardiovascular Markers in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis

    Claudia Mendoza-Pinto1, Mario Garcia-Carrasco1, Pamela Munguía-Realpozo2, Ivet Etchegaray-Morales2 and Socorro Mendez-Martínez1, 1Instituto Mexicano del Seguro Social, Puebla, Puebla, Mexico, 2Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Puebla, Mexico

    Background/Purpose: Cardiovascular morbidity and mortality is a well-established problem in patients with systemic lupus erythematosus (SLE). Hydroxychloroquine (HCQ) has been seen as a potential atheroprotective…
  • Abstract Number: 1260 • ACR Convergence 2020

    Longitudinal Relationships Between Depression, Anxiety and Cognition in Lupus

    Kathleen Bingham1, Juan Pablo Diaz-Martinez2, Mahta Kakvan2, Robin Green3, Dorcas Beaton4, Lesley Ruttan3, Carmela Tartaglia5, Marvin Fritzler6, May Choi7, Jiandong Su2, Denisse Bonilla8, Nicole Anderson2, Joan Wither2, Patricia Katz9 and Zahi Touma10, 1Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 2University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 3Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada, 4Institute for Work & Health, Toronto, ON, Canada, 5University of Toronto, Krembil Neurosciences Centre, Toronto, ON, Canada, 6Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 7Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 8University Health Network, Toronto, Canada, 9University of California, San Francisco, Novato, CA, 10University of Toronto, Toronto, ON, Canada

    Background/Purpose: There is a consistent relationship between cognition and depression and anxiety (affective symptoms) in lupus. Together, affective and cognitive symptoms represent among lupus’ most…
  • Abstract Number: 1261 • ACR Convergence 2020

    Antiphospholipid Patterns Predict the Risk of Thrombosis in Systemic Lupus Erythematosus

    Selcan Demir1, Jessica Li2, Laurence Magder3 and Michelle Petri4, 1Hacettepe University Faculty of Medicine, Ankara, Ankara, Turkey, 2Johns Hopkins University, Baltimore, MD, 3University of Maryland, Baltimore, Baltimore, MD, 4Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: Antiphospholipid syndrome (APS) has been classified as the development of venous and/or arterial thromboses, and/or pregnancy morbidity, in the presence of persistently raised levels…
  • Abstract Number: 1262 • ACR Convergence 2020

    Single LAC Positivity versus Double and Triple Positivity for Thrombosis in SLE

    Selcan Demir1, Jessica Li2, Laurence Magder3 and Michelle Petri4, 1Hacettepe University Faculty of Medicine, Ankara, Ankara, Turkey, 2Johns Hopkins University, Baltimore, MD, 3University of Maryland, Baltimore, Baltimore, MD, 4Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose:Antiphospholipid syndrome (APS) is classified as the development of venous and/or arterial thromboses, and pregnancy morbidity, in the presence of antiphospholipid antibodies (aPL); lupus anticoagulant,…
  • Abstract Number: 1263 • ACR Convergence 2020

    Association of the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) and Damage Accrual in Long Standing Systemic Lupus Erythematosus

    Kaitlin Lima1, Alexandra Legge2, John Hanly2, Jungwha Lee3, Jing Song3, Anh Chung3 and Rosalind Ramsey-Goldman4, 1Northwestern University, Chicago, IL, 2Dalhousie University, Halifax, NS, Canada, 3Northwestern University, Chicago, 4Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: The Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) was recently shown to predict mortality and damage accrual in the SLICC inception cohort. The…
  • Abstract Number: 1264 • ACR Convergence 2020

    Mortality in Patients with Systemic Lupus Erythematosus and Neuropsychiatric Symptoms

    Rory Monahan1, Rolf Fronczek1, Jeroen Eikenboom1, Huub Middelkoop1, Liesbeth Beaart-van de Voorde1, Gisela Terwindt1, Nic van der Wee1, Frits Rosendaal1, Thomas Huizinga1, Margreet Kloppenburg1 and Margreet Steup-Beekman1, 1Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Little is known about mortality in patients with systemic lupus erythematosus (SLE) presenting with neuropsychiatric (NP) symptoms. We aimed to evaluate all-cause and cause-specific…
  • « Previous Page
  • 1
  • …
  • 736
  • 737
  • 738
  • 739
  • 740
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology